Souad Nebchi

Affiliations

Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, Université Paris-Sud, UVSQ, Villejuif, France.

Publications (4)

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.

European journal of cancer (Oxford, England : 1990)

Avec: Raphael J Morscher , Caroline Brard , Pablo Berlanga , Lynley V Marshall , Nicolas André , Jonathan Rubino , Isabelle Aerts , Emilie De Carli , Nadège Corradini , Xavier Paoletti , Peter Mortimer , Ludovic Lacroix , Gaelle Pierron , Gudrun Schleiermacher , Gilles Vassal , Birgit Geoerger

Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research

Avec: Susanne A Gatz , Anne C Harttrampf , Caroline Brard , Francisco Bautista , Nicolas André , Samuel Abbou , Jonathan Rubino , Windy Rondof , Marc Deloger , Marc Rübsam , Lynley V Marshall , Daniel Hübschmann , Isabelle Aerts , Estelle Thebaud , Emilie De Carli , Anne Sophie Defachelles , Xavier Paoletti , Robert Godin , Kowser Miah , Peter G S Mortimer , Gilles Vassal , Birgit Geoerger

Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium.

European journal of cancer (Oxford, England : 1990)

Avec: Claudia Pasqualini , Jonathan Rubino , Caroline Brard , Lydie Cassard , Nicolas André , Windy Rondof , Jean-Yves Scoazec , Antonin Marchais , Lisa Boselli , Jonathan Grivel , Isabelle Aerts , Estelle Thebaud , Xavier Paoletti , Véronique Minard-Colin , Gilles Vassal , Birgit Geoerger

Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Avec: Francisco Bautista , Xavier Paoletti , Jonathan Rubino , Caroline Brard , Keyvan Rezai , Nicolas Andre , Isabelle Aerts , Emilie De Carli , Natasha van Eijkelenburg , Estelle Thebaud , Nadege Corradini , Anne-Sophie Defachelles , Stephane Ducassou , Raphael J Morscher , Gilles Vassal , Birgit Geoerger

Réseau de co-auteurs

Caroline Brard 4 collaborations

Jonathan Rubino 4 collaborations

Isabelle Aerts 4 collaborations

Xavier Paoletti 4 collaborations

Gilles Vassal 4 collaborations

Birgit Geoerger 4 collaborations

Nicolas André 3 collaborations

Emilie De Carli 3 collaborations

Estelle Thebaud 3 collaborations

Raphael J Morscher 2 collaborations

Lynley V Marshall 2 collaborations

Francisco Bautista 2 collaborations

Windy Rondof 2 collaborations

Pablo Berlanga 1 collaboration

Nadège Corradini 1 collaboration

Peter Mortimer 1 collaboration

Ludovic Lacroix 1 collaboration

Gaelle Pierron 1 collaboration

Gudrun Schleiermacher 1 collaboration

Susanne A Gatz 1 collaboration

Anne C Harttrampf 1 collaboration

Samuel Abbou 1 collaboration

Marc Deloger 1 collaboration

Marc Rübsam 1 collaboration

Daniel Hübschmann 1 collaboration

Anne Sophie Defachelles 1 collaboration

Robert Godin 1 collaboration

Kowser Miah 1 collaboration

Peter G S Mortimer 1 collaboration

Claudia Pasqualini 1 collaboration

Lydie Cassard 1 collaboration

Jean-Yves Scoazec 1 collaboration

Antonin Marchais 1 collaboration

Lisa Boselli 1 collaboration

Jonathan Grivel 1 collaboration

Véronique Minard-Colin 1 collaboration

Keyvan Rezai 1 collaboration

Nicolas Andre 1 collaboration

Natasha van Eijkelenburg 1 collaboration

Nadege Corradini 1 collaboration

Anne-Sophie Defachelles 1 collaboration

Stephane Ducassou 1 collaboration